DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (265)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 265   Next >>

Possible Rituxan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-25

Patient: male

Reactions: Dyspnoea, NO Therapeutic Response, Oedema Peripheral, Erythema

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2012-02-06

Rituxan
    Indication: Rheumatoid Arthritis
    Start date: 2012-08-01

Rituxan
    Start date: 2012-08-15



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: female

Reactions: Blood Pressure Increased, Urinary Tract Infection, Tremor, Paraesthesia, Peripheral Nerve Infection, Arthralgia, Diarrhoea, Blood Pressure, Colitis, Knee Arthroplasty, Feeling Abnormal, Sinusitis

Drug(s) suspected as cause:
Rituxan
    Start date: 2012-03-06

Rituxan
    Indication: Rheumatoid Arthritis
    Start date: 2011-09-03

Rituxan
    Start date: 2012-03-20

Other drugs received by patient: Gabapentin



Possible Rituxan side effects in 69 year old female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: 69 year old female

Reactions: Confusional State, Vertigo, Asthenia, Hallucination

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a physician from Canada on 2012-08-23

Patient: female, weighing 102.2 kg (224.7 pounds)

Reactions: Drug Intolerance, Headache, Infusion Related Reaction

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2012-01-27
    End date: 2012-01-27

Rituxan
    Indication: Rheumatoid Arthritis
    Start date: 2008-12-15

Rituxan

Other drugs received by patient: Atacand HCT; Nifedipine; Gliclazide; Acetaminophen; Methylprednisolone; Zofran; Januvia; Diphenhydramine HCL; Diamicron



Possible Rituxan side effects in 18 year old female

Reported by a pharmacist from United States on 2012-08-23

Patient: 18 year old female

Reactions: Haemolytic Anaemia, Thrombotic Thrombocytopenic Purpura

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Cyclophosphamide



Possible Rituxan side effects in female

Reported by a physician from United Kingdom on 2012-08-22

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Squamous Cell Carcinoma

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 32 year old female

Reported by a physician from Portugal on 2012-08-22

Patient: 32 year old female

Reactions: NO Therapeutic Response, Pregnancy

Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
    Indication: Systemic Lupus Erythematosus

Rituxan
    Indication: Systemic Lupus Erythematosus



Possible Rituxan side effects in female

Reported by a physician from United Kingdom on 2012-08-22

Patient: female

Reactions: Swelling Face, Joint Swelling, Insomnia, Rash Pruritic, Joint Stiffness

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female

Reactions: Wheelchair User, Muscular Weakness

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient: female

Reactions: Thrombosis, RED Blood Cell Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Procrit
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in

Reported by a consumer/non-health professional from United States on 2012-08-16

Patient:

Reactions: Weight Decreased, Unwanted Awareness During Anaesthesia, Dyspnoea, Lower Limb Fracture, Paraesthesia, Tremor, Irritability, Fatigue, Balance Disorder, Dizziness, Ulcer Haemorrhage, Papilloma Viral Infection, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan
    Indication: non-Hodgkin's Lymphoma
    Start date: 2005-01-01

Rituxan
    Dosage: late dec/2011 or jan/2012



Possible Rituxan side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Maternal Exposure Timing Unspecified, Lymphocyte Count Decreased

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-14

Patient: male

Reactions: Aphasia, Unevaluable Event, Hemiparesis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a pharmacist from United States on 2012-08-10

Patient: male

Reactions: Nausea, Chest Pain

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in

Reported by a pharmacist from United States on 2012-08-09

Patient:

Reactions: Breast Cancer

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-09

Patient: female

Reactions: Pneumonia, Diabetes Mellitus, Drug Ineffective, Condition Aggravated, Chronic Obstructive Pulmonary Disease, Dyspepsia, Oedema Peripheral, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Start date: 2011-11-30

Prednisone TAB
    Dosage: dose-variable. dose started years ago
    Administration route: Oral
    Indication: Vasculitis

Rituxan
    Indication: Wegener's Granulomatosis
    Start date: 2006-01-01

Rituxan
    Indication: Vasculitis
    Start date: 2011-08-25
    End date: 2011-09-16

Other drugs received by patient: Simvastatin; Cellcept; Lisinopril; Metformin Hydrochloride



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: female

Reactions: Metamorphopsia, Injection Site Pain, Sinusitis, Lymphoma

Drug(s) suspected as cause:
Lucentis
    Indication: AGE-Related Macular Degeneration
    Start date: 2009-07-01
    End date: 2012-07-01

Rituxan
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2005-01-01

Other drugs received by patient: Neupogen; Bendamustine Hydrochloride



Possible Rituxan side effects in

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient:

Reactions: Dyspnoea, Urticaria, Adverse Drug Reaction, Throat Tightness

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Remicade; Enbrel; Simponi; Orencia; Humira; Methotrexate; Cimzia



Possible Rituxan side effects in male

Reported by a physician from United States on 2012-08-01

Patient: male, weighing 5.0 kg (11.0 pounds)

Reactions: B-Lymphocyte Abnormalities, Maternal Exposure Timing Unspecified

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from Canada on 2012-07-30

Patient: female, weighing 61.3 kg (134.8 pounds)

Reactions: Chest Discomfort, Increased Upper Airway Secretion, HIP Arthroplasty, Oropharyngeal Pain, Rash, Headache, Flushing, Pharyngeal Disorder, Joint Swelling, Dysphonia, Cough

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Ascorbic Acid; Hydromorphone Hydrochloride; Naproxen; Lovaza



Possible Rituxan side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25

Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Pneumonia Fungal, Electrocardiogram QT Prolonged, Renal Disorder, Malnutrition, Disseminated Intravascular Coagulation, Clostridium Colitis, Gastric Ulcer, Pneumonia Cytomegaloviral, Liver Disorder, Hypokalaemia, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: uncertainty

Bactrim
    Dosage: unk

Cellcept
    Dosage: uncertainty
    Administration route: Oral

Cyclosporine
    Dosage: uncertainty

Decadron
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-05-20
    End date: 2011-06-17

Funguard
    Dosage: uncertainty

Meropenem
    Dosage: unk
    Indication: Prophylaxis

Rituxan

Romiplostim
    Dosage: 1 mg/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-06-01
    End date: 2011-06-08

Romiplostim
    Dosage: 2 mg/kg, qwk
    Start date: 2011-06-15
    End date: 2011-06-15

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2011-06-24
    End date: 2012-06-24

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-08-09
    End date: 2011-08-09

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-07-21
    End date: 2011-08-06

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-10-17

Romiplostim
    Dosage: 9 mg/kg, qwk
    Start date: 2011-09-08
    End date: 2011-09-08

Romiplostim
    Dosage: 4 mg/kg, qwk
    Start date: 2011-07-11
    End date: 2011-07-11

Romiplostim
    Dosage: 8 mg/kg, qwk
    Start date: 2011-09-01
    End date: 2011-09-01

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2012-06-21
    End date: 2012-06-21

Romiplostim
    Dosage: 6 mg/kg, qwk
    Start date: 2011-08-16
    End date: 2011-08-16

Romiplostim
    Dosage: 7 mg/kg, qwk
    Start date: 2011-08-24
    End date: 2011-08-24

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-09-15
    End date: 2011-10-13

Zosyn
    Dosage: unk

Other drugs received by patient: Prednisolone; Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Famotidine; Danazol; Danazol; Immune Globulin (Human); Cefazolin Sodium; Prednisolone; Prednisolone; Prednisolone; Prednisolone



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: female, weighing 94.4 kg (207.8 pounds)

Reactions: Abdominal Discomfort, Dyspnoea, Dysstasia, Dizziness, Asthenia, Ill-Defined Disorder, Blood Pressure Decreased

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Prednisolone; Sodium Chloride; Benadryl



Possible Rituxan side effects in

Reported by a physician from Italy on 2012-07-23

Patient:

Reactions: Neutropenia, Respiratory Tract Infection

Drug(s) suspected as cause:
Cladribine
    Dosage: for 5 consecutive days administered monthly for 4 cycles
    Indication: Waldenstrom's Macroglobulinaemia

Rituxan
    Dosage: on day 1 administered monthly for 4 cycles by infusion
    Indication: Waldenstrom's Macroglobulinaemia



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-23

Patient: female

Reactions: Abdominal Discomfort, Dyspnoea, Dysstasia, Dizziness, Ill-Defined Disorder, Blood Pressure Decreased, Asthenia

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Sodium Chloride; Benadryl; Prednisolone



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-18

Patient: female

Reactions: Systemic Lupus Erythematosus

Drug(s) suspected as cause:
Etanercept
    Indication: Rheumatoid Arthritis

Rituxan
    Indication: Rheumatoid Arthritis



Possible Rituxan side effects in

Reported by a physician from United States on 2012-07-17

Patient:

Reactions: Thrombosis, Gastrointestinal Perforation, Left Ventricular Dysfunction, Sudden Death, Blood Disorder, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Bevacizumab
    Dosage: on day 1, every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Rituxan
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: every 21 days for a maximum of 8 cycles
    Indication: Diffuse Large B-Cell Lymphoma



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: male

Reactions: Fungal Infection, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 2

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 3

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 4

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 3

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 4

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from Canada on 2012-07-17

Patient: female, weighing 61.3 kg (134.8 pounds)

Reactions: Chest Discomfort, Increased Upper Airway Secretion, HIP Arthroplasty, Rash, Oropharyngeal Pain, Headache, Dysphonia, Joint Swelling, Cough

Drug(s) suspected as cause:
Rituxan

Other drugs received by patient: Naproxen; Ascorbic Acid; Hydromorphone HCL; Lovaza



Possible Rituxan side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Rituxan
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Rituxan side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-17

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Weight Decreased, Oral Candidiasis, Dehydration, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1320 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Cyclophosphamide
    Dosage: 1350 mg, unk
    Start date: 2012-01-23

Cyclophosphamide
    Dosage: 1275 mg, unk
    Start date: 2012-02-13

Doxorubicin HCL
    Dosage: 88 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Doxorubicin HCL
    Dosage: 90 mg, unk
    Start date: 2012-01-23

Doxorubicin HCL
    Dosage: 85 mg, unk
    Start date: 2012-02-13

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-02-14

Pegfilgrastim
    Dosage: 6 mg, unk
    Start date: 2012-01-28

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-10

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-01-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-13

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2012-02-17

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-23

Rituxan
    Dosage: 600 mg, unk
    Start date: 2012-02-18

Rituxan
    Dosage: 600 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Rituxan
    Dosage: 700 mg, unk
    Start date: 2012-01-23

Vincristine
    Dosage: 42 mg, unk
    Start date: 2012-01-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-09

Vincristine
    Dosage: 2 mg
    Start date: 2012-02-13

Other drugs received by patient: Morphine Sulfate; Pantoprazole; Mirtazapine; Tenoretic; Simvastatin; Venlafaxine Hydrocholride; Simvastatin; Simvastatin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014